Literature DB >> 3474660

Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia.

B Angelin, K S Hershon, J D Brunzell.   

Abstract

This study was undertaken to characterize bile acid metabolism in hereditary forms of hypertriglyceridemia. Ten hypertriglyceridemic patients (type IV phenotype) with familial combined hyperlipidemia and 7 patients with monogenic familial hypertriglyceridemia (FHTG) were compared with 18 healthy controls; all subjects were males. Pool size, synthesis rate, and fractional catabolic rate of cholic and chenodeoxycholic acids were determined with an isotope dilution technique. Patients with FHTG had synthesis rates of cholic acid, chenodeoxycholic acid, and total bile acids above those seen in normal controls (P less than 0.001); also the fractional catabolic rates of both bile acids were increased (P less than 0.001). In contrast, bile acid kinetic parameters were--with one exception--within normal limits in patients with familial combined hyperlipidemia. The abnormality of bile acid metabolism could also be identified in a normolipidemic individual presumed to carry the gene for FHTG. The postprandial rise of serum bile acids was blunted in FHTG, indicating that the intestinal uptake of bile acids may be deficient in this condition. We conclude that FHTG, but not familial combined hyperlipidemia, is frequently associated with a defective regulation of bile acid synthesis, resulting in abnormally high production rate of bile acids. It is hypothesized that this abnormality is important for the subsequent development of hypertriglyceridemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474660      PMCID: PMC298872          DOI: 10.1073/pnas.84.15.5434

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The turnover of cholic acid in man: bile acids and steroids.

Authors:  S LINDSTEDT
Journal:  Acta Physiol Scand       Date:  1957-09-17

2.  Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia.

Authors:  A Chait; J J Albers; J D Brunzell
Journal:  Eur J Clin Invest       Date:  1980-02       Impact factor: 4.686

3.  Cholestyramine treatment reduces postprandial but not fasting serum bile acid levels in humans.

Authors:  B Angelin; I Björkhem; K Einarsson; S Ewerth
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

4.  Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.

Authors:  A H Kissebah; S Alfarsi; P W Adams
Journal:  Metabolism       Date:  1981-09       Impact factor: 8.694

5.  Bile acid kinetics in relation to endogenous tryglyceride metabolism in various types of hyperlipoproteinemia.

Authors:  B Angelin; K Einarsson; K Hellström; B Leijd
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

6.  Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia.

Authors:  B Angelin; K Einarsson; K Hellström; B Leijd
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

7.  Individual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size.

Authors:  B Angelin; I Bjökhem; K Einarsson
Journal:  J Lipid Res       Date:  1978-07       Impact factor: 5.922

8.  Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides.

Authors:  U Beil; J R Crouse; K Einarsson; S M Grundy
Journal:  Metabolism       Date:  1982-05       Impact factor: 8.694

9.  Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects.

Authors:  E D Janus; A M Nicoll; P R Turner; P Magill; B Lewis
Journal:  Eur J Clin Invest       Date:  1980-04       Impact factor: 4.686

10.  Triglyceride and cholesterol metabolism in primary hypertriglyceridemia.

Authors:  U Beil; S M Grundy; J R Crouse; L Zech
Journal:  Arteriosclerosis       Date:  1982 Jan-Feb
View more
  18 in total

1.  Activated charcoal in the treatment of hypercholesterolaemia: dose-response relationships and comparison with cholestyramine.

Authors:  P J Neuvonen; P Kuusisto; H Vapaatalo; V Manninen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.

Authors:  Ian M Johnston; Jonathan D Nolan; Sanjeev S Pattni; Richard N Appleby; Justine H Zhang; Sarah L Kennie; Gaganjit K Madhan; Sina Jameie-Oskooei; Shivani Pathmasrirengam; Jeremy Lin; Albert Hong; Peter H Dixon; Catherine Williamson; Julian R F Walters
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

Review 3.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 4.  Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype.

Authors:  M A Austin
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 5.  Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis.

Authors:  Yang Jiao; Yan Lu; Xiao-ying Li
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

6.  Mechanisms of triglyceride metabolism in patients with bile acid diarrhea.

Authors:  Nidhi Midhu Sagar; Michael McFarlane; Chuka Nwokolo; Karna Dev Bardhan; Ramesh Pulendran Arasaradnam
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

7.  Physical activity as a determinant of fecal bile acid levels.

Authors:  Betsy C Wertheim; María Elena Martínez; Erin L Ashbeck; Denise J Roe; Elizabeth T Jacobs; David S Alberts; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

8.  Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.

Authors:  T Hayek; N Azrolan; R B Verdery; A Walsh; T Chajek-Shaul; L B Agellon; A R Tall; J L Breslow
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

9.  Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.

Authors:  S Reynisdottir; M Eriksson; B Angelin; P Arner
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection.

Authors:  Ju-Hee Kang; Minji Kim; Mijung Yim
Journal:  Biochem Biophys Rep       Date:  2021-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.